Contraception最新文献

筛选
英文 中文
Copyright info/Contents 版权信息/内容
IF 2.3 2区 医学
Contraception Pub Date : 2025-08-30 DOI: 10.1016/S0010-7824(25)00382-8
{"title":"Copyright info/Contents","authors":"","doi":"10.1016/S0010-7824(25)00382-8","DOIUrl":"10.1016/S0010-7824(25)00382-8","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"150 ","pages":"Article 111191"},"PeriodicalIF":2.3,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144917913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Copyright info/Contents 版权信息/内容
IF 2.3 2区 医学
Contraception Pub Date : 2025-07-29 DOI: 10.1016/S0010-7824(25)00213-6
{"title":"Copyright info/Contents","authors":"","doi":"10.1016/S0010-7824(25)00213-6","DOIUrl":"10.1016/S0010-7824(25)00213-6","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"149 ","pages":"Article 111022"},"PeriodicalIF":2.3,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144725059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to “A pilot efficacy study with a single-rod contraceptive implant (Implanon®1) in 200 Indonesian women treated for ≤ 4 years” [Contraception 59/3 (1999) 167–174] 撤回“200名印度尼西亚妇女使用单棒避孕植入物(Implanon®1)治疗≤4年的试点疗效研究”[避孕59/3(1999)167-174]。
IF 2.3 2区 医学
Contraception Pub Date : 2025-07-24 DOI: 10.1016/j.contraception.2025.110999
Biran Affandi , Tjeerd Korver , T.B. Paul Geurts , Herjan J.T. Coelingh Bennink
{"title":"Retraction notice to “A pilot efficacy study with a single-rod contraceptive implant (Implanon®1) in 200 Indonesian women treated for ≤ 4 years” [Contraception 59/3 (1999) 167–174]","authors":"Biran Affandi , Tjeerd Korver , T.B. Paul Geurts , Herjan J.T. Coelingh Bennink","doi":"10.1016/j.contraception.2025.110999","DOIUrl":"10.1016/j.contraception.2025.110999","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"150 ","pages":"Article 110999"},"PeriodicalIF":2.3,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to immediate postpartum long-acting reversible contraceptive provision in China: A qualitative study from the perspective of service providers 中国产后立即提供长效可逆避孕措施的障碍:基于服务提供者视角的定性研究
IF 2.3 2区 医学
Contraception Pub Date : 2025-07-23 DOI: 10.1016/j.contraception.2025.111040
Jinfeng Qian , Yan Zhang , Yuyan Li , Yi Zhang , Yan Che
{"title":"Barriers to immediate postpartum long-acting reversible contraceptive provision in China: A qualitative study from the perspective of service providers","authors":"Jinfeng Qian ,&nbsp;Yan Zhang ,&nbsp;Yuyan Li ,&nbsp;Yi Zhang ,&nbsp;Yan Che","doi":"10.1016/j.contraception.2025.111040","DOIUrl":"10.1016/j.contraception.2025.111040","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to explore the barriers to immediate postpartum long-acting reversible contraception provision (LARC) from the perspective of obstetric health care providers in China.</div></div><div><h3>Study design</h3><div>The qualitative study involved hospital deputy directors, obstetric department chiefs, doctors, and nurses from obstetric departments in four hospitals (two in the eastern and two in the western regions of China). Data were collected through semistructured interviews and analyzed using thematic analysis.</div></div><div><h3>Results</h3><div>The study included 46 participants recruited from four hospitals that all offered intrauterine devices (IUDs) and implants but not immediate postpartum LARC services. Findings reveal that while all four hospitals offered IUDs and implants, none of their obstetric departments provided immediate postpartum LARC services. Significant barriers identified were the immediate postpartum LARC provision was not within the providers job responsibilities; the reluctance of most providers to recommend hormonal contraceptive methods to postpartum people due to concerns about the impact on breastfeeding and infant health; the nonprovision of immediate postpartum IUD placement was primarily due to fears of increased side effects such as pain, bleeding, and expulsion rates; and the provision might lead to potential medicolegal concerns.</div></div><div><h3>Conclusions</h3><div>The study reaches the conclusion that there are substantial barriers to the provision of postpartum LARC. These barriers mainly consist of concerns about reluctance to get involved in unnecessary trouble due to extra work, side effects, lack of knowledge about immediate postpartum LARC placement, and apprehensions regarding the potential impact on the doctor-patient relationship.</div></div><div><h3>Implications</h3><div>This study identifies key barriers to immediate postpartum long-acting reversible contraception provision in China, including provider concerns about side effects, lack of motivations, and limited policy support. Addressing these challenges through targeted interventions could improve long-acting reversible contraception provision, benefiting postpartum people in clinical practice.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"150 ","pages":"Article 111040"},"PeriodicalIF":2.3,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaginal contraception with NuvaRing decreases symptoms and uterine features of adenomyosis: A prospective evaluation 阴道避孕NuvaRing@减少子宫腺肌症的症状和子宫特征。前瞻性评价。
IF 2.3 2区 医学
Contraception Pub Date : 2025-07-14 DOI: 10.1016/j.contraception.2025.111016
Anjeza Xholli , Francesca Oppedisano , Mattia Francesco Ferraro , Isabella Perugi , Ambrogio P. Londero , Angelo Cagnacci
{"title":"Vaginal contraception with NuvaRing decreases symptoms and uterine features of adenomyosis: A prospective evaluation","authors":"Anjeza Xholli ,&nbsp;Francesca Oppedisano ,&nbsp;Mattia Francesco Ferraro ,&nbsp;Isabella Perugi ,&nbsp;Ambrogio P. Londero ,&nbsp;Angelo Cagnacci","doi":"10.1016/j.contraception.2025.111016","DOIUrl":"10.1016/j.contraception.2025.111016","url":null,"abstract":"<div><h3>Objective</h3><div>We aimed to assess the effects of contraception with NuvaRing on ultrasound signs and symptoms of women with adenomyosis.</div></div><div><h3>Study design</h3><div>We conducted a prospective self-controlled observational study on women with adenomyosis who required contraception with NuvaRing. Exclusion criteria were actual use or contraindications to hormonal contraception. NuvaRing was administered in a continuous regimen, one ring every 3 weeks without hormone-free intervals, to avoid menses. Adenomyosis, suggested by clinical signs, was confirmed by ultrasonography. Before and after 6 months of NuvaRing, we evaluated uterine volume, direct and indirect ultrasound signs of adenomyosis, and the severity of menstrual, intermenstrual pain, and pain during intercourse, by a 10-cm visual analog scale (VAS).</div></div><div><h3>Result(s)</h3><div>This study included 42 women, 30.0 ± 4.5 years old, with a BMI of 22.8 ± 1.8 kg/m². All were nulliparous except one. Following 6 months of NuvaRing, uterine volume decreased of 14.4 ± 13.5% (<em>p</em> = 0.001). A similar decrease was observed in six women switching from dienogest. Direct ultrasound signs of adenomyosis per patient (total signs/n women) decreased from 0.5 (range 0–3) to 0.08 (range 0–2) (<em>p</em> = 0.003), and indirect signs, from 2.8 (range 1–5) to 1.5 (range 0–5) (<em>p</em> = 0.001). The VAS for menstrual pain decreased from 8.3 ± 1.2 to 3.9 ± 2.5 (<em>p</em> = 0.001), for intermenstrual pain from 6.6 ± 1.4 to 2.9 ± 1.7 (<em>p</em> = 0.001), and for pain during intercourse from 7.0 ± 1.4 to 2.9 ± 1.7 (<em>p</em> = 0.001). The decrease of menstrual pain was significantly associated with the reduction of uterine volume (<em>p</em> = 0.003).</div></div><div><h3>Conclusion(s)</h3><div>Our findings demonstrate that contraception with NuvaRing is a viable contraceptive option for women with adenomyosis.</div></div><div><h3>Implications</h3><div>In women with adenomyosis contraception with NuvaRing is useful and can be proposed because it reduces the clinical signs and the uterine ultrasound features of adenomyosis.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"150 ","pages":"Article 111016"},"PeriodicalIF":2.3,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144651531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspectives on options for self-sourcing medication abortion after implementation of Texas Senate Bill 8 得克萨斯州参议院第8号法案实施后自主外包药物流产选择的视角。
IF 2.3 2区 医学
Contraception Pub Date : 2025-07-11 DOI: 10.1016/j.contraception.2025.111017
Whitney Arey , Klaira Lerma , Anna Chatillon , Kari White
{"title":"Perspectives on options for self-sourcing medication abortion after implementation of Texas Senate Bill 8","authors":"Whitney Arey ,&nbsp;Klaira Lerma ,&nbsp;Anna Chatillon ,&nbsp;Kari White","doi":"10.1016/j.contraception.2025.111017","DOIUrl":"10.1016/j.contraception.2025.111017","url":null,"abstract":"<div><h3>Objectives</h3><div>To examine experiences of pregnant Texans who considered self-sourcing medication abortion following the September 2021 implementation of Texas Senate Bill 8, which prohibited abortions after detectable embryonic cardiac activity.</div></div><div><h3>Study design</h3><div>This qualitative research study used in-depth telephone interviews conducted between October 2021 and August 2022 with pregnant and recently pregnant Texas residents ≥16 years of age who considered abortion. We recruited participants from two sources: flyers posted at abortion facilities in nearby states and an online survey of Texans seeking abortion care. We interviewed participants who obtained out-of-state abortion care or who reported self-managing their abortion, having a miscarriage or an ectopic pregnancy, or continuing their pregnancy. We used inductive and deductive coding in our thematic analysis examining perceptions of self-sourcing medication abortion and potential use of a hypothetical telehealth abortion model.</div></div><div><h3>Results</h3><div>Of the 120 participants interviewed, 50 researched or considered self-sourcing medication abortion, including 15 who ultimately sourced medications to self-manage their abortion. Participants described uncertainty about the safety and legality of their options for self-sourcing abortion medications, and most would have preferred to use telehealth abortion in a hypothetical legal policy context, including those who self-managed their abortion.</div></div><div><h3>Conclusions</h3><div>In the context of an abortion ban, people considered self-sourcing abortion medications, but had concerns about the legality and safety of doing so. People in states with restrictive abortion laws may benefit from information about how to access medication abortion from safe and reliable sources and mitigate their legal risks.</div></div><div><h3>Implications</h3><div>People perceive meaningful differences between the legality and safety of telehealth and self-managed medication abortion. Strategies are needed to provide pregnant people in restricted settings with clear information so they can make an informed choice for their personal circumstances.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"150 ","pages":"Article 111017"},"PeriodicalIF":2.3,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144628023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel approach to cervical dilation for second-trimester dilation and evacuation in a myomatous uterus 子宫肌瘤患者妊娠中期宫颈扩张和子宫引流的新方法。
IF 2.3 2区 医学
Contraception Pub Date : 2025-07-10 DOI: 10.1016/j.contraception.2025.111008
Sarah J. Gross, Lauren Kus, Adam Jacobs, Ariella Goldman
{"title":"A novel approach to cervical dilation for second-trimester dilation and evacuation in a myomatous uterus","authors":"Sarah J. Gross,&nbsp;Lauren Kus,&nbsp;Adam Jacobs,&nbsp;Ariella Goldman","doi":"10.1016/j.contraception.2025.111008","DOIUrl":"10.1016/j.contraception.2025.111008","url":null,"abstract":"<div><div>Cervical preparation prior to dilation and evacuation can be challenging in the presence of uterine or cervical fibroids. In cases of distorted cervical anatomy, a transcervical Foley balloon with stylet can be considered to achieve cervical dilation.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"150 ","pages":"Article 111008"},"PeriodicalIF":2.3,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144621544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Communication with patients using asynchronous telehealth medication abortion services 异步远程医疗流产药物服务与患者的沟通。
IF 2.3 2区 医学
Contraception Pub Date : 2025-07-09 DOI: 10.1016/j.contraception.2025.111014
Anna E Fiastro , Nikeeta Shah , Rebecca Gomperts , Jessica D Gipson , Emily M Godfrey
{"title":"Communication with patients using asynchronous telehealth medication abortion services","authors":"Anna E Fiastro ,&nbsp;Nikeeta Shah ,&nbsp;Rebecca Gomperts ,&nbsp;Jessica D Gipson ,&nbsp;Emily M Godfrey","doi":"10.1016/j.contraception.2025.111014","DOIUrl":"10.1016/j.contraception.2025.111014","url":null,"abstract":"<div><h3>Objectives</h3><div>Understanding patient communication with clinic providers or staff in telemedicine abortion can inform appropriate staffing.</div></div><div><h3>Methodology</h3><div>We describe patient-service communication when using asynchronous telemedicine abortion services from April to November 2020 (<em>n</em> = 504) and compare patient demographics with number of messages using Kruskal-Wallis rank sum test.</div></div><div><h3>Results</h3><div>About half of patients communicated with staff (56%, <em>n</em> = 287), median of six messages per patient (interquartile range: 3–10 messages). Primary topics included (1) eligibility, (2) payment, (3) medication delivery, and (4) physical process. Message volume did not differ by patient demographics.</div></div><div><h3>Conclusions</h3><div>Our findings inform communication and staffing quantity and quality in telemedicine abortion provision.</div></div><div><h3>Implications</h3><div>Asynchronous telehealth abortion patients require minimal communication, and most inquiries can be addressed by nonclinical staff. These insights can inform resource allocation and staffing decisions in telehealth abortion services, improving efficiency while maintaining patient satisfaction.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"150 ","pages":"Article 111014"},"PeriodicalIF":2.3,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144621545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obstetrics and gynecology resident experiences in an abortion-ban state post-Dobbs 多布斯后堕胎禁令州的妇产科住院医师经历。
IF 2.3 2区 医学
Contraception Pub Date : 2025-07-05 DOI: 10.1016/j.contraception.2025.111011
Lana Nguyen , Sophie Ulene , Julia E. Kohn , Erika Levi
{"title":"Obstetrics and gynecology resident experiences in an abortion-ban state post-Dobbs","authors":"Lana Nguyen ,&nbsp;Sophie Ulene ,&nbsp;Julia E. Kohn ,&nbsp;Erika Levi","doi":"10.1016/j.contraception.2025.111011","DOIUrl":"10.1016/j.contraception.2025.111011","url":null,"abstract":"<div><h3>Objective</h3><div>To explore the impact of the June 24, 2022, antiabortion legislation (<em>Dobbs</em>) on trainees, we examined the experiences of obstetrics and gynecology (OBGYN) residents within a single program in a state with a complete abortion ban with rare exceptions.</div></div><div><h3>Study design</h3><div>We conducted semistructured interviews with OBGYN residents at an institution in an abortion ban state. Domains of inquiry included residency selection process, experiences with/attitudes toward abortion training, perspectives on legislation and advocacy, and career plans. We conducted thematic analysis of transcribed interviews, which were coded by two independent coders using Dedoose.</div></div><div><h3>Results</h3><div>We enrolled 19 participants from May to December 2023, representing trainees from all years who entered the program between 2018 and 2023. We identified four main themes: (1) Abortion restrictions increased residents’ moral distress and frustration due to strain on the patient-physician relationship, increased barriers to care, and decreased quality of care; (2) Residents receiving abortion training post-<em>Dobbs</em> reported concerns about clinical competence due to decreased volume at their institution and away rotation. (3) Residents considered availability of abortion training in residency program choice more highly after the <em>Dobbs</em> decision. (4) Practicing in an abortion-restricted state reinforces residents’ desires to receive abortion training and informs where they choose to practice after graduation.</div></div><div><h3>Conclusions</h3><div>In a residency program where post-<em>Dobbs</em> legislation aresulted in one of the most restrictive abortion bans, OBGYN residents reported an impact on their well-being amid increasing patient care challenges, concerns of competence due to limited abortion training, and a desire for future abortion provision.</div></div><div><h3>Implications</h3><div>This study highlights the significant impact of the <em>Dobbs</em> decision on OBGYN trainees in abortion-restricted states. By revealing how these restrictions affect residents' training, well-being, and career choices, our findings underscore the urgent need for adaptive strategies to ensure comprehensive abortion education in a rapidly evolving legal landscape.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"150 ","pages":"Article 111011"},"PeriodicalIF":2.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144585852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experience of nulliparous patients aged <30 years seeking permanent female contraception: A qualitative study 30岁以下未生育患者寻求永久性女性避孕的经验:一项定性研究。
IF 2.3 2区 医学
Contraception Pub Date : 2025-07-04 DOI: 10.1016/j.contraception.2025.111010
Marielle E. Meurice , Kendahl Wallis-Lang , Marisa C. Hildebrand , Tim K. Mackey , Sheila K. Mody
{"title":"Experience of nulliparous patients aged <30 years seeking permanent female contraception: A qualitative study","authors":"Marielle E. Meurice ,&nbsp;Kendahl Wallis-Lang ,&nbsp;Marisa C. Hildebrand ,&nbsp;Tim K. Mackey ,&nbsp;Sheila K. Mody","doi":"10.1016/j.contraception.2025.111010","DOIUrl":"10.1016/j.contraception.2025.111010","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to describe the experience of nulliparous individuals aged &lt;30 years when seeking permanent female contraception.</div></div><div><h3>Study design</h3><div>We recruited nulliparous individuals aged &lt;30 years who underwent permanent female contraception in the United States in the last 2 years through a clinical Listserv, Facebook, and Reddit to participate in semistructured in-depth interviews. We summarized themes using the socioecological model.</div></div><div><h3>Results</h3><div>Thirty individuals from 20 states participated. The average age was 25 years (range 21–30). Most participants identified as White (25, 83%), non-Latine (28, 93%), had attended some college (27, 90%), and used online resources to seek permanent female contraception (22, 73%). On an individual level, childfree identity and the experience of trying other contraception methods led participants to choose permanent female contraception. On an interpersonal level, participants reported others’ support of bodily autonomy and childfree identity as facilitators and questioning permanent female contraception decisions as a barrier. On an institutional level, insurance coverage created confusion and stress. At the community level, social media interactions provided information and support. At the public policy level, the <em>Dobbs</em> decision increased the urgency to seek permanent female contraception.</div></div><div><h3>Conclusions</h3><div>This qualitative study of young, nulliparous individuals focuses on characterizing patients’ lived experiences and motivations for seeking permanent female contraception. Key findings included support stemming from a clinician’s acceptance of childfree identity, stressors from insurance coverage, benefits of using online resources, and the impact of the <em>Dobbs</em> decision on the urgency to seek permanent female contraception due to perceived threats to reproductive autonomy.</div></div><div><h3>Implications</h3><div>This study provides insights into the perspectives of young, nulliparous people who underwent permanent female contraception. Clinicians’ acceptance of childfree-identity and online resources are facilitators, and the <em>Dobbs</em> decision impacted urgency of seeking surgery. Findings should be integrated into policy and practice for improved person-centered care in a post-<em>Dobbs</em> society.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"150 ","pages":"Article 111010"},"PeriodicalIF":2.3,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144577261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信